Regulators

Crypto hoarding brings a stock pop for small firms—and in some cases shows patterns of possible insider trading
Cancer drug developer MEI Pharma saw its stock almost double in the days before it committed to a crypto treasury strategy.
Cancer drug developer MEI Pharma saw its stock almost double in the days before it committed to a crypto treasury strategy.